These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 19139387)

  • 21. Drug copayment and adherence in chronic heart failure: effect on cost and outcomes.
    Cole JA; Norman H; Weatherby LB; Walker AM
    Pharmacotherapy; 2006 Aug; 26(8):1157-64. PubMed ID: 16863491
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lowering copayments: impact of simvastatin patent expiration on patient adherence.
    Sedjo RL; Cox ER
    Am J Manag Care; 2008 Dec; 14(12):813-8. PubMed ID: 19067498
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Variation in prescription use and spending for lipid-lowering and diabetes medications in the Veterans Affairs Healthcare System.
    Gellad WF; Good CB; Lowe JC; Donohue JM
    Am J Manag Care; 2010 Oct; 16(10):741-50. PubMed ID: 20964470
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adherence to sleep apnea therapy and use of lipid-lowering drugs: a study of the healthy-user effect.
    Platt AB; Kuna ST; Field SH; Chen Z; Gupta R; Roche DF; Christie JD; Asch DA
    Chest; 2010 Jan; 137(1):102-8. PubMed ID: 19820075
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association between prescription burden and medication adherence in patients initiating antihypertensive and lipid-lowering therapy.
    Benner JS; Chapman RH; Petrilla AA; Tang SS; Rosenberg N; Schwartz JS
    Am J Health Syst Pharm; 2009 Aug; 66(16):1471-7. PubMed ID: 19667004
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of copayments on drug use in the presence of annual payment limits.
    Kephart G; Skedgel C; Sketris I; Grootendorst P; Hoar J
    Am J Manag Care; 2007 Jun; 13(6 Pt 2):328-34. PubMed ID: 17567233
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of 3-tier formularies on drug treatment of attention-deficit/hyperactivity disorder in children.
    Huskamp HA; Deverka PA; Epstein AM; Epstein RS; McGuigan KA; Muriel AC; Frank RG
    Arch Gen Psychiatry; 2005 Apr; 62(4):435-41. PubMed ID: 15809411
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Copayments for medication in 2014. Final rule.
    Department of Veterans Affairs
    Fed Regist; 2014 May; 79(101):30043-4. PubMed ID: 24864365
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association Between Copayment and Adherence to Medications for Pulmonary Arterial Hypertension.
    Schikowski EM; Swabe G; Chan SY; Magnani JW
    J Am Heart Assoc; 2022 Nov; 11(22):e026620. PubMed ID: 36370005
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potential bias in medication adherence studies of prevalent users.
    Maciejewski ML; Bryson CL; Wang V; Perkins M; Liu CF
    Health Serv Res; 2013 Aug; 48(4):1468-86. PubMed ID: 23402554
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Copayments for medications. Final rule.
    Department of Veterans Affairs
    Fed Regist; 2010 Jun; 75(110):32668-70. PubMed ID: 20524258
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship of the use and costs of physician office visits and prescription drugs to travel distance and increases in member cost share.
    Cecil WT; Barnes J; Shea T; Coulter SL
    J Manag Care Pharm; 2006 Oct; 12(8):665-76. PubMed ID: 17269845
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association between statin adherence and cholesterol level reduction from baseline in a veteran population.
    Kazerooni R; Watanabe JH; Bounthavong M
    Pharmacotherapy; 2013 Oct; 33(10):1044-52. PubMed ID: 23744794
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increasing pharmaceutical copayments: impact on asthma medication utilization and outcomes.
    Campbell JD; Allen-Ramey F; Sajjan SG; Maiese EM; Sullivan SD
    Am J Manag Care; 2011 Oct; 17(10):703-10. PubMed ID: 22106463
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of copayments for prescriptions on adherence to prescription medicines in publicly insured populations; a systematic review and meta-analysis.
    Sinnott SJ; Buckley C; O'Riordan D; Bradley C; Whelton H
    PLoS One; 2013; 8(5):e64914. PubMed ID: 23724105
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of Medication Copayment on Adherence and Discontinuation in Medicare Beneficiaries with Type 2 Diabetes: A Retrospective Administrative Claims Database Analysis.
    Pawaskar MD; Xu L; Tang Y; Puckrein GA; Rajpathak SN; Stuart B
    Diabetes Ther; 2018 Oct; 9(5):1979-1993. PubMed ID: 30143964
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary non-adherence to prescribed medication in general practice: lack of influence of moderate increases in patient copayment.
    Linnet K; Halldórsson M; Thengilsdóttir G; Einarsson ÓB; Jónsson K; Almarsdóttir AB
    Fam Pract; 2013 Feb; 30(1):69-75. PubMed ID: 22964077
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparing adherence and persistence across 6 chronic medication classes.
    Yeaw J; Benner JS; Walt JG; Sian S; Smith DB
    J Manag Care Pharm; 2009; 15(9):728-40. PubMed ID: 19954264
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Provider adherence to clinical guidelines related to lipid-lowering medications.
    Cohen SM; Kataoka-Yahiro M
    Mil Med; 2010 Feb; 175(2):122-6. PubMed ID: 20180482
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Copayments for medications in 2012. Final rule.
    Department of Veterans Affairs
    Fed Regist; 2012 May; 77(93):28258-9. PubMed ID: 22606731
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.